MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, EMMA had $738K increase in cash & cash equivalents over the period. -$12K in free cash flow.

Cash Flow Overview

Change in Cash
$738K
Free Cash flow
-$12K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from notes payable issu...
    • Accounts payable and accrued exp...
    • Proceeds from sale of convertibl...
    • Others
Negative Cash Flow Breakdown
    • Payments of notes payable
    • Net loss
    • (gain) loss on leased assets
    • Others

Cash Flow
2025-12-31
Net loss
-7,492
Depreciation and amortization
39
Inventory reserve
-111
Amortization of discount of notes payable and convertible notes payable
560
Foreign exchange adjustments
38
Realized loss on investment in convertible bond
-531
Loss on debt extinguishment
-1,363
(gain) loss on leased assets
861
Share-based compensation
25
Change in fair value of warrant derivative liabilities
-5
Change in fair value of conversion feature derivative, notes payable
162
Accounts receivable
182
Inventories
21
Prepaid expenses and other current assets
140
Other non-current assets
-323
Accounts payable and accrued expenses
6,456
Other liabilities
-184
Operating lease liabilities
-344
Net cash flows used in operating activities
-11
Proceeds from sale of convertible bond
2,172
Purchases of property and equipment
1
Net cash flows provided by investing activities
2,171
Proceeds from notes payable issued
7,908
Payments of notes payable
8,883
Payments of notes payable, related party
240
Payments of convertible notes
210
Net cash flows used in financing activities
-1,425
Effect of exchange rate changes on cash
3
Net increase (decrease) in cash and cash equivalents
738
Cash and cash equivalents, beginning of year
1,389
Cash and cash equivalents, end of year
2,127
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofconvertible bond$2,172K Net cash flowsprovided by investing...$2,171K Effect of exchange ratechanges on cash$3K Canceled cashflow$1K Net increase(decrease) in cash and cash...$738K Canceled cashflow$1,436K Purchases of property andequipment$1K Proceeds from notespayable issued$7,908K Accounts payable andaccrued expenses$6,456K Loss on debtextinguishment-$1,363K Amortization of discount ofnotes payable and...$560K Realized loss oninvestment in convertible...-$531K Other non-currentassets-$323K Inventory reserve-$111K Depreciation andamortization$39K Share-based compensation$25K Change in fair value ofwarrant derivative...-$5K Net cash flows usedin financing...-$1,425K Net cash flows usedin operating...-$11K Canceled cashflow$7,908K Canceled cashflow$9,413K Payments of notes payable$8,883K Net loss-$7,492K Payments of notespayable, related party$240K Payments of convertiblenotes$210K (gain) loss on leasedassets$861K Operating leaseliabilities-$344K Other liabilities-$184K Accounts receivable$182K Change in fair value ofconversion feature...$162K Prepaid expenses andother current assets$140K Foreign exchangeadjustments$38K Inventories$21K

Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences, Inc. (EMMA)